培美曲塞化疗后晚期非小细胞肺癌患者出现泪溢 - Suppr

Epiphora following chemotherapy with pemetrexed in patients with advanced non-small cell lung cancer.

作者信息

Jung Yun Duk, Lee Sang Bin, Jung Yun Wha, Song Jung Sub, Woo In Sook

机构信息

Division of Hematology and Medical Oncology, Department of Internal Medicine, College of Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

Division of Pulmonology, Department of Internal Medicine, College of Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

出版信息

Korean J Intern Med. 2017 Sep;32(5):923-925. doi: 10.3904/kjim.2015.042. Epub 2017 Mar 18.

DOI:10.3904/kjim.2015.042

PMID:28298078

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5583437/

Abstract

摘要

相似文献

Epiphora following chemotherapy with pemetrexed in patients with advanced non-small cell lung cancer.

Korean J Intern Med. 2017 Sep;32(5):923-925. doi: 10.3904/kjim.2015.042. Epub 2017 Mar 18.

Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer.

Lung Cancer. 2015 Aug;89(2):154-60. doi: 10.1016/j.lungcan.2015.05.003. Epub 2015 May 12.

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients.

Lung Cancer. 2015 Jun;88(3):319-24. doi: 10.1016/j.lungcan.2015.03.016. Epub 2015 Apr 1.

Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.

Cancer Chemother Pharmacol. 2015 Oct;76(4):771-6. doi: 10.1007/s00280-015-2843-3. Epub 2015 Aug 11.

Lipodermatosclerosis secondary to pemetrexed use.

J Thorac Oncol. 2015 Mar;10(3):e11-2. doi: 10.1097/JTO.0000000000000426.

Pemetrexed and interstitial lung disease.

Acta Oncol. 2016;55(4):521-2. doi: 10.3109/0284186X.2015.1080859. Epub 2015 Sep 14.

[Role of pemetrexed in the treatment of advanced non-small-cell lung cancer: news from ASCO, 2008].

Tumori. 2008 Sep-Oct;94(5):suppl 3-13.

Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial.

Lung Cancer. 2016 Dec;102:65-73. doi: 10.1016/j.lungcan.2016.10.011. Epub 2016 Oct 27.

Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-naïve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II study.

Cancer Chemother Pharmacol. 2013 Aug;72(2):445-52. doi: 10.1007/s00280-013-2218-6. Epub 2013 Jun 27.

Estimated Creatinine Clearance Rate Is Associated With the Treatment Effectiveness and Toxicity of Pemetrexed As Continuation Maintenance Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Clin Lung Cancer. 2015 Nov;16(6):e131-40. doi: 10.1016/j.cllc.2015.01.001. Epub 2015 Jan 10.

本文引用的文献

Skin toxicities compromise prolonged pemetrexed treatment.

J Thorac Oncol. 2011 Dec;6(12):2083-9. doi: 10.1097/JTO.0b013e31822e722f.

Ocular complications of cancer therapy: a primer for the ophthalmologist treating cancer patients.

Curr Opin Ophthalmol. 2009 Jul;20(4):308-17. doi: 10.1097/ICU.0b013e32832c9007.

Hypersensitivity Reactions to oxaliplatin: incidence and management.

Oncology (Williston Park). 2004 Nov;18(13):1671-5; discussion 1676, 1680, 1683-4.

FDA drug approval summaries: pemetrexed (Alimta).

Oncologist. 2004;9(5):482-8. doi: 10.1634/theoncologist.9-5-482.

Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa.

Ophthalmic Plast Reconstr Surg. 2003 Jul;19(4):305-8. doi: 10.1097/01.IOP.0000075016.29682.E0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Epiphora following chemotherapy with pemetrexed in patients with advanced non-small cell lung cancer.

作者信息

Jung Yun Duk, Lee Sang Bin, Jung Yun Wha, Song Jung Sub, Woo In Sook

机构信息

Division of Hematology and Medical Oncology, Department of Internal Medicine, College of Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

Division of Pulmonology, Department of Internal Medicine, College of Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

出版信息

Korean J Intern Med. 2017 Sep;32(5):923-925. doi: 10.3904/kjim.2015.042. Epub 2017 Mar 18.

DOI:10.3904/kjim.2015.042

PMID:28298078

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5583437/

Abstract

摘要

相似文献

Epiphora following chemotherapy with pemetrexed in patients with advanced non-small cell lung cancer.

Korean J Intern Med. 2017 Sep;32(5):923-925. doi: 10.3904/kjim.2015.042. Epub 2017 Mar 18.

Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer.

Lung Cancer. 2015 Aug;89(2):154-60. doi: 10.1016/j.lungcan.2015.05.003. Epub 2015 May 12.

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients.

Lung Cancer. 2015 Jun;88(3):319-24. doi: 10.1016/j.lungcan.2015.03.016. Epub 2015 Apr 1.

Cancer Chemother Pharmacol. 2015 Oct;76(4):771-6. doi: 10.1007/s00280-015-2843-3. Epub 2015 Aug 11.

Lipodermatosclerosis secondary to pemetrexed use.

J Thorac Oncol. 2015 Mar;10(3):e11-2. doi: 10.1097/JTO.0000000000000426.

Pemetrexed and interstitial lung disease.

Acta Oncol. 2016;55(4):521-2. doi: 10.3109/0284186X.2015.1080859. Epub 2015 Sep 14.

[Role of pemetrexed in the treatment of advanced non-small-cell lung cancer: news from ASCO, 2008].

Tumori. 2008 Sep-Oct;94(5):suppl 3-13.

Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial.

Lung Cancer. 2016 Dec;102:65-73. doi: 10.1016/j.lungcan.2016.10.011. Epub 2016 Oct 27.

Cancer Chemother Pharmacol. 2013 Aug;72(2):445-52. doi: 10.1007/s00280-013-2218-6. Epub 2013 Jun 27.

Estimated Creatinine Clearance Rate Is Associated With the Treatment Effectiveness and Toxicity of Pemetrexed As Continuation Maintenance Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Clin Lung Cancer. 2015 Nov;16(6):e131-40. doi: 10.1016/j.cllc.2015.01.001. Epub 2015 Jan 10.

本文引用的文献

Skin toxicities compromise prolonged pemetrexed treatment.

J Thorac Oncol. 2011 Dec;6(12):2083-9. doi: 10.1097/JTO.0b013e31822e722f.

Ocular complications of cancer therapy: a primer for the ophthalmologist treating cancer patients.

Curr Opin Ophthalmol. 2009 Jul;20(4):308-17. doi: 10.1097/ICU.0b013e32832c9007.

Hypersensitivity Reactions to oxaliplatin: incidence and management.

Oncology (Williston Park). 2004 Nov;18(13):1671-5; discussion 1676, 1680, 1683-4.

FDA drug approval summaries: pemetrexed (Alimta).

Oncologist. 2004;9(5):482-8. doi: 10.1634/theoncologist.9-5-482.

Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa.

Ophthalmic Plast Reconstr Surg. 2003 Jul;19(4):305-8. doi: 10.1097/01.IOP.0000075016.29682.E0.

Epiphora following chemotherapy with pemetrexed in patients with advanced non-small cell lung cancer.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Epiphora following chemotherapy with pemetrexed in patients with advanced non-small cell lung cancer.

作者信息

机构信息

出版信息

相似文献

本文引用的文献